To amend the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public-Private Partnerships.

H.R. 7658 · 117th Congress · May 3, 2022 · Lineage

A BILL

Section 1 Reauthorization of the Critical Path Public-Private Partnerships

Section 566(f) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360bbb–5(f)) is amended by striking “$6,000,000 for each of fiscal years 2018 through 2022” and inserting “$10,000,000 for each of fiscal years 2023 through 2027”.

To amend the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public-Private Partnerships.

Section 1 Reauthorization of the Critical Path Public-Private Partnerships

Cite this provision

Incoming references